Author Correction: Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2045-2322
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Author Correction: Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression ; volume:12 ; number:1 ; day:18 ; month:10 ; year:2022 ; pages:1 ; date:12.2022
Scientific reports ; 12, Heft 1 (18.10.2022), 1, 12.2022

Creator
Siafarikas, Nikias
Kirsebom, Bjørn-Eivind
Srivastava, Deepak P.
Eriksson, Cecilia M.
Auning, Eirik
Hessen, Erik
Selbaek, Geir
Blennow, Kaj
Aarsland, Dag
Fladby, Tormod
Contributor
SpringerLink (Online service)

DOI
10.1038/s41598-022-22274-1
URN
urn:nbn:de:101:1-2023010321092882452463
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Siafarikas, Nikias
  • Kirsebom, Bjørn-Eivind
  • Srivastava, Deepak P.
  • Eriksson, Cecilia M.
  • Auning, Eirik
  • Hessen, Erik
  • Selbaek, Geir
  • Blennow, Kaj
  • Aarsland, Dag
  • Fladby, Tormod
  • SpringerLink (Online service)

Other Objects (12)

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress

Fluid biomarkers in Alzheimer’s disease – current concepts

Fluid biomarkers in Alzheimer’s disease – current concepts

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders

Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease

Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease

Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium

Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium

Related objects